Reportedly, miR-124 also inhibits bone metastasis by suppressing interleukin 11 (IL11) expression in breast cancer cells, regulating osteoclastogenesis, and reducing osteolysis [96]. The gene discussed is IL11; the disease is breast carcinoma.